These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34352700)

  • 1. Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPN.
    Kricheldorf K; Döhner K; Stegelmann F; Jost PJ; Lang F; Radsak M; Hansen R; Heuer V; Röhrig R; Brümmendorf TH; Koschmieder S; Isfort S
    Leuk Res; 2021 Nov; 110():106646. PubMed ID: 34352700
    [No Abstract]   [Full Text] [Related]  

  • 2. High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.
    Barbui T; Vannucchi AM; Alvarez-Larran A; Iurlo A; Masciulli A; Carobbio A; Ghirardi A; Ferrari A; Rossi G; Elli E; Andrade-Campos MM; Kabat MG; Kiladjian JJ; Palandri F; Benevolo G; Garcia-Gutierrez V; Fox ML; Foncillas MA; Morcillo CM; Rumi E; Osorio S; Papadopoulos P; Bonifacio M; Cervantes KSQ; Serrano MS; Carreno-Tarragona G; Sobas MA; Lunghi F; Patriarca A; Elorza BN; Angona A; Mazo EM; Koschmieder S; Ruggeri M; Cuevas B; Hernandez-Boluda JC; Abadia EL; Cirici BX; Guglielmelli P; Garrote M; Cattaneo D; Daffini R; Cavalca F; Bellosillo B; Benajiba L; Curto-Garcia N; Bellini M; Betti S; De Stefano V; Harrison C; Rambaldi A
    Leukemia; 2021 Feb; 35(2):485-493. PubMed ID: 33414483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism.
    Lucijanic M; Krecak I; Soric E; Sedinic M; Sabljic A; Derek L; Jaksic O; Kusec R
    Blood Cancer J; 2021 Nov; 11(11):189. PubMed ID: 34845183
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term follow-up of recovered MPN patients with COVID-19.
    Barbui T; Iurlo A; Masciulli A; Carobbio A; Ghirardi A; Rossi G; Harrison C; Alvarez-Larran A; Elli EM; Kiladjian JJ; Gasior Kabat M; Marin Sanchez A; Palandri F; Andrade-Campos MM; Vannucchi AM; Carreno-Tarragona G; Papadopoulos P; Quiroz Cervantes K; Angeles Foncillas M; Fox ML; Sagues Serrano M; Rumi E; Osorio S; Benevolo G; Patriarca A; Navas Elorza B; Garcia-Gutierrez V; Magro Mazo E; Lunghi F; Bonifacio M; De Stefano V; Hernandez-Boluda JC; Lopez Abadia E; Angona A; Xicoy Cirici B; Ruggeri M; Koschmieder S; Sobas MA; Cuevas B; Cattaneo D; Daffini R; Bellini M; Curto-Garcia N; Garrote M; Cavalca F; Benajiba L; Bellosillo B; Guglielmelli P; Borsani O; Betti S; Salmoiraghi S; Rambaldi A
    Blood Cancer J; 2021 Jun; 11(6):115. PubMed ID: 34135309
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
    Salisbury RA; Curto-Garcia N; O'Sullivan J; Chen F; Polzella P; Godfrey AL; Russell J; Knapper S; Willan J; Frewin R; Joshi S; Arami S; Burns S; Teh CH; Wadelin F; Dhanapal J; Neelakantan P; Milojkovic D; Psaila B; Szydlo R; Francis S; Cargo C; Jain M; McGregor A; Wallis L; Duncombe A; Hussein H; Dyer P; Munro L; Bond L; McMullin MF; Somervaille TCP; Garg M; Sekhar M; Harrison C; Mead AJ; Innes AJ
    Leukemia; 2021 Aug; 35(8):2424-2430. PubMed ID: 33580204
    [No Abstract]   [Full Text] [Related]  

  • 6. Second versus first wave of COVID-19 in patients with MPN.
    Barbui T; Iurlo A; Masciulli A; Carobbio A; Ghirardi A; Carioli G; Sobas MA; Elli EM; Rumi E; De Stefano V; Lunghi F; Marchetti M; Daffini R; Gasior Kabat M; Cuevas B; Fox ML; Andrade-Campos MM; Palandri F; Guglielmelli P; Benevolo G; Harrison C; Foncillas MA; Bonifacio M; Alvarez-Larran A; Kiladjian JJ; Bolaños Calderón E; Patriarca A; Quiroz Cervantes K; Griessammer M; Garcia-Gutierrez V; Marin Sanchez A; Magro Mazo E; Ruggeri M; Hernandez-Boluda JC; Osorio S; Carreno-Tarragona G; Sagues Serrano M; Kusec R; Navas Elorza B; Angona A; Xicoy Cirici B; Lopez Abadia E; Koschmieder S; Cattaneo D; Bucelli C; Cichocka E; Masternak Kulikowska de Nałęcz A; Cavalca F; Borsani O; Betti S; Benajiba L; Bellini M; Curto-Garcia N; Rambaldi A; Vannucchi AM
    Leukemia; 2022 Mar; 36(3):897-900. PubMed ID: 35064223
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators.
    Jairath V; Guizzetti L; Baker KA; Williamson LA; Sedano R; Thompson H; Ma C
    Inflamm Bowel Dis; 2021 Jul; 27(8):e98. PubMed ID: 33988238
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience.
    Cattaneo D; Bucelli C; Cavallaro F; Consonni D; Iurlo A
    Blood Cancer J; 2021 Nov; 11(11):185. PubMed ID: 34824194
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time.
    Cattaneo C; Pagani C; Cancelli V; Imberti L; Roccaro AM; Notarangelo LD; Rossi G
    Leukemia; 2021 Feb; 35(2):632-634. PubMed ID: 32770087
    [No Abstract]   [Full Text] [Related]  

  • 10. Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies.
    Mazza GL; Kunze KL; Langlais BT; Kosiorek HE; DeWees TA; Geyer HL; Scherber RM; Mesa RA; Dueck AC
    Leuk Lymphoma; 2019 Jul; 60(7):1789-1795. PubMed ID: 30652523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany.
    Engelhardt M; Shoumariyeh K; Rösner A; Ihorst G; Biavasco F; Meckel K; von Metzler I; Treurich S; Hebart H; Grube M; Kull M; Bassermann F; Schäfer-Eckart K; Hoferer A; Einsele H; Rasche L; Wäsch R
    Haematologica; 2020 Dec; 105(12):2872-2878. PubMed ID: 33256391
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of telemedicine to maintain breast cancer follow-up and surveillance during the COVID-19 pandemic.
    Sonagli M; Cagnacci Neto R; Leite FPM; Makdissi FBA
    J Surg Oncol; 2021 Feb; 123(2):371-374. PubMed ID: 33333581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.
    Mesa R; Miller CB; Thyne M; Mangan J; Goldberger S; Fazal S; Ma X; Wilson W; Paranagama DC; Dubinski DG; Boyle J; Mascarenhas JO
    BMC Cancer; 2016 Feb; 16():167. PubMed ID: 26922064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    Harrington P; Harrison CN; Dillon R; Radia DH; Rezvani K; Raj K; Woodley C; Curto-Garcia N; O'Sullivan J; Saunders J; Kordasti S; Ali S; de Lavallade H; McLornan DP
    Br J Haematol; 2021 May; 193(4):692-696. PubMed ID: 33719038
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.
    Schmidt AL; Bakouny Z; Bhalla S; Steinharter JA; Tremblay DA; Awad MM; Kessler AJ; Haddad RI; Evans M; Busser F; Wotman M; Curran CR; Zimmerman BS; Bouchard G; Jun T; Nuzzo PV; Qin Q; Hirsch L; Feld J; Kelleher KM; Seidman D; Huang HH; Anderson-Keightly HM; Abou Alaiwi S; Rosenbloom TD; Stewart PS; Galsky MD; Choueiri TK; Doroshow DB
    Cancer Cell; 2020 Dec; 38(6):769-770. PubMed ID: 33176161
    [No Abstract]   [Full Text] [Related]  

  • 16. People living with type 1 diabetes point of view in COVID-19 times (COVIDT1 study): Disease impact, health system pitfalls and lessons for the future.
    Tejera-Perez C; Moreno-Pérez Ó; Rios J; Reyes-García R
    Diabetes Res Clin Pract; 2021 Jan; 171():108547. PubMed ID: 33278422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): An international survey of contemporary practice.
    Hargreaves R; Harrison CN; McLornan DP
    Curr Res Transl Med; 2022 Jul; 70(3):103338. PubMed ID: 35217310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptance of Telerheumatology by Rheumatologists and General Practitioners in Germany: Nationwide Cross-sectional Survey Study.
    Muehlensiepen F; Knitza J; Marquardt W; Engler J; Hueber A; Welcker M
    J Med Internet Res; 2021 Mar; 23(3):e23742. PubMed ID: 33690147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality of high-risk orthopaedic oncology patients during the COVID-19 pandemic: A prospective cohort study.
    Stevenson JD; Evans S; Morris G; Tillman R; Abudu A; Jeys L; Parry M
    J Surg Oncol; 2020 Nov; 122(6):1027-1030. PubMed ID: 32668015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.
    Krahling T; Balassa K; Kiss KP; Bors A; Batai A; Halm G; Egyed M; Fekete S; Remenyi P; Masszi T; Tordai A; Andrikovics H
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):98-104. PubMed ID: 26487696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.